Pharmacodynamics, safety, and immunogenicity of Pelmeg<sup>®</sup>, a pegfilgrastim biosimilar in healthy subjects

Hendrik Wessels, Dirk Lehnick, Josef Höfler, Ruediger Jankowsky, Paul Chamberlain, Karsten Roth

Open source

DOI
10.1002/prp2.507
Published
2019-08-13
Container
Pharmacology Research &amp; Perspectives
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/prp2.507,
  title = {Pharmacodynamics, safety, and immunogenicity of Pelmeg<sup>®</sup>, a pegfilgrastim biosimilar in healthy subjects},
  author = {Hendrik Wessels and Dirk Lehnick and Josef Höfler and Ruediger Jankowsky and Paul Chamberlain and Karsten Roth},
  year = {2019},
  journal = {Pharmacology Research \&amp; Perspectives},
  doi = {10.1002/prp2.507},
  url = {https://doi.org/10.1002/prp2.507}
}

RIS

TY  - JOUR
TI  - Pharmacodynamics, safety, and immunogenicity of Pelmeg<sup>®</sup>, a pegfilgrastim biosimilar in healthy subjects
AU  - Hendrik Wessels
AU  - Dirk Lehnick
AU  - Josef Höfler
AU  - Ruediger Jankowsky
AU  - Paul Chamberlain
AU  - Karsten Roth
PY  - 2019
JO  - Pharmacology Research &amp; Perspectives
DO  - 10.1002/prp2.507
UR  - https://doi.org/10.1002/prp2.507
ER  - 

APA

Wessels, H., Lehnick, D., Höfler, J., Jankowsky, R., Chamberlain, P., & Roth, K. (2019). Pharmacodynamics, safety, and immunogenicity of Pelmeg<sup>®</sup>, a pegfilgrastim biosimilar in healthy subjects. Pharmacology Research &amp; Perspectives. https://doi.org/10.1002/prp2.507

Source records